Concepedia

An investigational new drug treatment program for patients with gemcitabine

Anna Maria Storniolo, Nathan Enas, Cheryl A. Brown, Maurizio Voi, Mace L. Rothenberg, Richard L. Schilsky

Cancer · 1999 · 261 citations · 10 references

DOI

Abstract

Notable disease-related symptom improvement and survival were seen with gemcitabine in this large, compassionate-use setting, and these findings were in agreement with those of earlier registration trials.

References

10

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

Howard A. Burris, Malcolm J. Moore, John Sahl Andersen et al. · Journal of Clinical Oncology · 1997 · 5.8K citations

Censored Data and the Bootstrap

Bradley Efron · Journal of the American Statistical Association · 1981 · 647 citations

, , +13

A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer

Mace L. Rothenberg, Malcolm J. Moore, M. Christine Cripps et al. · Annals of Oncology · 1996 · 569 citations · Full text

, , +7

Phase II trial of gemcitabine (2,2′-difiuorodeoxycytidine) in patients with adenocarcinoma of the pancreas

Ephraim S. Casper, Mark R. Green, David P. Kelsen et al. · Investigational New Drugs · 1994 · 440 citations

, , +5

Phase II study of gemcitabine in patients with advanced pancreatic cancer

J Carmichael, U. Fink, RC Russell et al. · British Journal of Cancer · 1996 · 370 citations · Full text

, , +7